Sundial is aware of an online article involving a commercial relationship with another Licensed Producer. There were factual inaccuracies in the article. While Sundial cannot comment on specific customer agreements due to contractual confidentiality, we can confirm that this isolated immaterial matter is being resolved between Sundial and the Licensed Producer. There is no impact on Q2 financial reporting and we anticipate that the impact on Q3 earnings will be negligible. Sundial follows strict Good Production Practices (GPP) in accordance with all Health Canada standards. Our company also uses standard provisions for potential returns which is consistent with industry practice.
Sundial is committed to producing safe, innovative and high-quality products.
Sundial Growers (Nasdaq: SNDL) (“Sundial”) announced today that it will release its second quarter financial results ended June 30, 2020 after market close on August 13, 2020.Read More
Sundial today announced that it will participate in a virtual event as part of Alliance Global Partners’ series ‘The Cannabis Chronicles’.Read More
Sundial Announces Successful Amendments with Senior Lenders, US$18 Million Convertible Notes Issuance and Close of Bridge Farm Sale.Read More